Skip to main content
. 2004 May;78(9):4761–4775. doi: 10.1128/JVI.78.9.4761-4775.2004

TABLE 1.

Neurovirulence of ChimeriVax-DEN1-4 viruses at various Vero passages in 4-day-old mice

Virus chimera Expt Passagea Amino acid changesb Dose (BT)c Mortality (no. of dead/total no.) LD50 (log10 PFU)
DEN1 1 P7 (PMS) None 3.1, 2.1 10/11, 8/11 <2.1
P8 (GMP MS) E204K→R 2.6, 1.6 7/11, 8/11 <1.6
P9 NDd 4.1, 3.1 2/11, 3/11 >4.1
P10 E204K→R 5.1, 4.1, 3.1 1/13, 1/13, 0/12 >5.1
2 P7 None 2.9, 1.9 10/10, 8/10 <1.9
P20 E204K→R, NS4b23 (S→I), NS4b98(V→I) 3.8, 2.8 0/9, 0/9 >3.8
DEN2 1 P7 (PMS) None 3.3, 2.3 11/11, 8/11 <2.3
P8 (GMP MS) prM24L→V, E251V→F 2.0, 1.0 11/11, 9/11 <1.0
P9 ND 3.8, 2.8 11/12, 10/12 <2.8
P10 prM24L→V, E251V→F 4.0, 3.0, 2.0 11/12, 10/13, 5/13 2.7
2 P7 (PMS) None 3.3, 2.3, 1.3 10/10, 8/10, 6/10 1.3
P20 prM24L→V, E251V→F 3.6, 2.6, 1.6 7/9, 4/10, 2/9 3.5
DEN3 1 P7 (PMS) None 3.6 4/12 >3.6
P8 (GMP MS) None 3.5 3/12 >3.5
P9 ND 4.0, 3.0 0/13, 0/13 >4.0
P10 E202K→R 3.7, 2.7 0/13, 0/13 >3.7
2 P7 (PMS) None 4.6, 3.6 2/10, 2/10 >4.6
P20 NS4b177L→F 4.1, 3.1 0/10, 0/10 >4.1
DEN4 1 P7 (PMS) None 2.3, 1.3 9/11, 6/11 2.2
P8 (GMP MS) None 2.5, 1.5 11/12, 9/11 <1.5
P9 ND 2.4, 1.4 8/11, 1/12 1.9
P10 None 4.0, 3.0, 2.0 12/13, 7/13, 4/13 2.4
2 P7 (PMS) None 2.6, 1.6, 0.6 4/11, 3/11, 0/11 >2.6
P20 None 3.7, 2.7, 1.7 2/11, 1/11, 0/11 >3.7
YF-VAX 1 None NAd 2.2 15/15 <2.2
2 None NA 2.2 9/9 <2.2
a

P9 and P10 viruses were produced in the research laboratory by two passages of GMP MS (P8) in Vero cells.

b

No silent mutation was found in any viruses except for DEN3 virus (a nucleotide change in NS4A6607 was found in all passages of DEN3 virus chimeras).

c

Doses were determined by back titer determination (BT) of inocula.

d

ND, not done; NA, not applicable.

HHS Vulnerability Disclosure